Jane Holmes

University of Oxford - Nuffield Department of Primary Care Health Sciences

Oxford

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 22,460

SSRN RANKINGS

Top 22,460

in Total Papers Downloads

4,488

SSRN CITATIONS

4

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

Number of pages: 43 Posted: 17 Oct 2022
University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford - Nuffield Department of Primary Care Health Sciences, University College London - UCL Institute of Immunity and Transplantation, University College London - Department of Infection, Inflammation and Immunity, University College London - Department of Infection, Inflammation and Immunity, University of Liverpool - Department of Molecular and Clinical Pharmacology, University of Oxford - Nuffield Department of Primary Care Health Sciences, Cardiff University - Centre for Trials Research, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, Windrush Medical Practice, University of Exeter - Faculty of Health and Life Sciences, University of Oxford - Oxford Respiratory Trials Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Glasgow - Institute of Health and Wellbeing, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, NHS Foundation Trust - Oxford University Hospitals, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, North Manchester General Hospital - Regional Infectious Diseases Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences and University of Southampton - Primary Care and Population Science
Downloads 4,297 (4,730)

Abstract:

Loading...

COVID-19, clincial trial, antiviral agents, primary health care, molnupiravir

2.

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Number of pages: 38 Posted: 07 May 2024
University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University College London - UCL Institute of Immunity and Transplantation, University College London, University College London - Department of Infection, Inflammation and Immunity, University of Liverpool, University of Oxford - Nuffield Department of Primary Care Health Sciences, Cardiff University, Cardiff University, Cardiff University - Centre for Trials Research, University of Nottingham, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, University of Southampton - Primary Care Research Centre, Windrush Medical Practice, University of Exeter - Faculty of Health and Life Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Glasgow - Institute of Health and Wellbeing, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, North Manchester General Hospital - Regional Infectious Diseases Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton, University of Oxford - Nuffield Department of Primary Care Health Sciences and Independent
Downloads 157 (366,127)
Citation 1

Abstract:

Loading...

SARS-CoV-2, Primary Care, COVID-19, Randomized controlled trial, Long term follow-up

3.

Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study

Number of pages: 38 Posted: 29 Jan 2024
Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford, University of Oxford, University of Cambridge - Department of Oncology, University College London - UCL Cancer Institute, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford, University of Oxford, Velindre Cancer Centre, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, Imperial College London - Hammersmith Hospital, Department of Cancer Medicine, University of Cambridge, NHS Foundation Trust - Norfolk and Norwich University Hospital, Government of the United Kingdom - Hull University Teaching Hospitals NHS Trust, Coventry University - Coventry University Hospital, Cardiff University - Centre for Trials Research, University of Leeds - Institute of Medical Research, University of Oxford - MRC Oxford Institute for Radiation Oncology, University College London - Department of Medical Physics and Biomedical Engineering and University of Cambridge
Downloads 34 (863,632)

Abstract:

Loading...

Pancreatic cancer, Chemoradiotherapy, Nelfinavir, Dose escalation, Survival, Outcomes, Toxicity, Health-related quality of life